Morning Overview on MSN
Trial: Estradiol patches match injections for prostate cancer care
A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...
CNN — (CNN) — President Joe Biden’s diagnosis of metastatic prostate cancer has understandably raised concerns and questions: How long has he had cancer, how will he be treated, and what is his ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
Metastasis, the spread of cancer from a primary tumor to other parts of the body, is difficult to study in the lab, in part ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive ...
Clinical and pathologic characteristics of mCRPC were largely similar between younger and older patients. Overall survival was not significantly different between younger and older patients with mCRPC ...
Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...
The Gleason score reliably predicts lethal prostate cancer for up to 25 years after diagnosis. High-grade prostate cancers progress rapidly in the short term, while lower grade tumors can still lead ...
On track to share data from first two dose levels in 2H 2026Targeting KLK3 and leveraging the dual emission of Tb161 represents an innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results